Is the P value goin to be strong enough with such small numbers ? This is part of the problem we ran into with CD12. I know the dosage is higher but I fear that we are making the same mistakes we made last time with lowering enrollment numbers. I know we don’t have many options but I guess I just don’t want to see us make these mistakes again.